Home > Research > Publications & Outputs > Notch Signalling as a Therapeutic Target in Cancer

Electronic data


Text available via DOI:

View graph of relations

Notch Signalling as a Therapeutic Target in Cancer

Research output: Contribution to journalLiterature review

<mark>Journal publication date</mark>10/2016
<mark>Journal</mark>International Journal of Cancer Therapy and Oncology
Issue number4
Publication statusPublished
Original languageEnglish


Notch signalling is a conserved developmental pathway involved, inter alia, in cell-fate decision, morphogenesis and tissue patterning. Extensive research has linked this pathways with a variety of malignancies, cancer stem cell renewal, induction of epithelial-to-mesenchymal transition and tumor angiogenesis. These data indicate that Notch can act as both a tumor suppressor and an oncoprotein, depending upon cellular context and identify it as a potential therapeutic target in cancer treatment. This review discusses the implications of Notch in a number of hematologic and solid malignancies and some of the currently available inhibitors developed against this pathway as potential cancer therapeutics.